Avstera Therapeutics Corp.
Ajay Raju is a seasoned professional with extensive experience in leadership and law. Currently serving as Co-Founder and Director at Avstera Therapeutics Inc. since January 2022, Raju also holds key positions as Founder & Chairman of THE ARK INSTITUTE and Chairman of Raju LLP and Indigo Global, among several other organizations. Raju co-founded The Germination Project and The Philadelphia Citizen, exemplifying a commitment to community engagement and entrepreneurship. Additionally, Raju is the Managing General Partner of 215 Capital and previously held the roles of Chairman & CEO at Dilworth Paxson LLP and Managing Partner at Reed Smith. Raju earned a JD from Temple University - James E. Beasley School of Law and a degree from Temple University.
This person is not in any teams
Avstera Therapeutics Corp.
Specialty oncology-focused biopharmaceutical company based in Malvern, PA with a broad pipeline encompassing novel best in class selective HDAC6i immunomodulators and a game changing myeloid based discovery platform. Avstera focuses on foundational tumor biology science, while methodologically breaking barriers using cutting-edge approaches in order to deliver impactful treatments to cancer patients.